Health
Chronicle Pharmabiz
Gene therapy, rapid test seen as a new hope for SCD: Experts
HIGH-tech gene therapy with affordable diagnostic tools is seen to be a groundbreaking leap for sickle cell disease (SCD) care in India.
2 min |
July 17, 2025
Chronicle Pharmabiz
Lupin Diagnostics achieves NABL certification for all greenfield labs
LUPIN Diagnostics, a wholly owned subsidiary of global pharma major Lupin Limited (Lupin), has achieved 100 per cent NABL (National Accreditation Board for Testing and Calibration Laboratories) accreditation across all its greenfield labs.
1 min |
July 17, 2025
Chronicle Pharmabiz
Investors invited to transform India's API landscape
A high-level government delegation led by the R D Nazeem, Additional Chief Secretary (Industries), Himachal Pradesh (HP), is embarking on a strategic mission in Mumbai to engage with key stakeholders and investors in the ambitious Himachal Pradesh Bulk Drug Park Infrastructure Ltd. (HPBDPIL) project.
1 min |
July 17, 2025
Chronicle Pharmabiz
Industry concerned over moisture menace altering colour, taste of medicines
THE Indian pharmaceutical industry is now concerned over the moisture menace which alters the colour, smell, and taste of medicines.
2 min |
July 17, 2025
Chronicle Pharmabiz
Pharmexcil, USP discuss collaboration on biosimilar accessibility
THE Pharmaceuticals Export Promotion Council of India (Pharmexcil) has discussed synergies with the United States Pharmacopoeia (USP) to ensure access to biosimilars particularly in lowand middle-income countries, identify high-risk APIs prone to shortages and global best practices as part of the USP resolutions for 2025-2030.
2 min |
July 17, 2025
Chronicle Pharmabiz
HC asks CCSEA to inspect Palamur Bio
THE Delhi High Court (HC) has asked the Committee for Control and Supervision of Experiments on Animals (CCSEA) to conduct an inspection along with the representatives of the People for the Ethical Treatment of Animals India (PETA India) and submit a status report within four weeks regarding the animal experiments and related issues in Telangana-based Palamur Biosciences.
2 min |
July 17, 2025
Chronicle Pharmabiz
DGTR initiates investigation on MAA from China
THE Directorate General of Trade Remedies (DGTR), under the ministry of commerce and industry, Government of India, has initiated sunset review investigation concerning the anti-dumping duty on methyl acetoacetate (MAA) imported from China.
1 min |
July 17, 2025
Chronicle Pharmabiz
Indian pharma powers ahead with research on NDDS
INDIAN Pharma is undergoing a significant transformation, not just in discovering novel therapeutics, but in its mode of innovative drug delivery.
2 min |
July 17, 2025
Chronicle Pharmabiz
Omron, Tricog launch KeeboHealth for cardiac care
OMRON Healthcare, a global leader in innovative home health monitoring solutions, has expanded its collaboration with Tricog Health, an Al-driven cardiac care company, to launch KeeboHealth, an advanced connected health platform designed to transform remote cardiac care and accelerate progress toward Omron's ambitious 'Going for Zero' vision, a world with zero cardiovascular events.
1 min |
July 17, 2025
Chronicle Pharmabiz
'Small pharma cos struggle with revised Schedule M compliance'
SMALL pharma companies are unprepared for the revised Schedule M even as the deadline for its implementation December 31, 2025 looms large.
1 min |
July 17, 2025
Chronicle Pharmabiz
Clinical trial applications for CGTP made online mode
As part of its ongoing efforts to streamline the processes through digitisation, the Central Drugs Standard Control Organisation (CDSCO) has switched over from offline acceptance of clinical trial applications for cell and gene therapeutics products (CGTP) to online mode.
1 min |
July 17, 2025
Chronicle Pharmabiz
ISB-MIHM reveals attitudes on AI for TB diagnosis
INDIAN School of Business (ISB) with researchers at the Max Institute of Healthcare Management (MIHM) have uncovered significant insights into healthcare providers' attitudes toward artificial intelligence (AI) in tuberculosis (TB) diagnosis, highlighting both opportunities and challenges in implementing AI-based healthcare solutions in India.
1 min |
July 17, 2025
Chronicle Pharmabiz
BDMAI to launch e-marketing portal for APIs, pellets
THE Bulk Drug Manufacturers Association of India (BDMAI) is planning to launch an exclusive e-marketing portal for the Indian active pharmaceutical ingredients (API), intermediates, pellets and pharma services to offer their products and services to the national and international markets.
1 min |
July 17, 2025
Chronicle Pharmabiz
DCC agrees with proposal to amend entry on liquid antiseptics under Sch K
THE Drugs Consultative Committee (DCC) has agreed with a proposal to amend the Drugs Rules, 1945 to bring in changes to the extent and conditions for exemption of liquid antiseptics for household use from wholesale license and hospital grade antiseptic from retail sale license under the Schedule K of Drugs Rules, 1945.
1 min |
July 17, 2025
Chronicle Pharmabiz
US FDA accepts Milestone's Cardamyst for review
MILESTONE Pharmaceuticals Inc., a biopharmaceutical company developing and commercializing innovative cardiovascular solutions, announced that the US FDA has accepted for review of Milestone’s response to issues raised in the Complete Response Letter (CRL) for Cardamyst (etripamil) nasal spray, an investigational, novel therapy for the treatment of patients with paroxysmal supraventricular tachycardia (PSVT).
1 min |
July 17, 2025
Chronicle Pharmabiz
Suraksha Diagnostics ties up with United Imaging
SURAKSHA Diagnostics, a leading diagnostics service provider in Eastern India has announced its collaboration with United Imaging, a global leader in advanced imaging technologies, with an aim to establish more than 20 new imaging centres across Eastern India.
1 min |
July 17, 2025
Chronicle Pharmabiz
Klotho's KLTO-202 gets US FDA orphan drug status
KLOTHO Neurosciences, Inc, a gene and cell therapy company focused on the treatment of neurodegenerative and other aging-related diseases, announced that the US FDA has granted orphan drug designation to the company's novel secreted-Klotho (s-KL) promoter, gene and delivery system (KLTO-202, or s-KL-AAV. myo) for the treatment of amyotrophic lateral sclerosis (ALS).
1 min |
July 17, 2025
Chronicle Pharmabiz
India's expertise in robotic surgeries draws global patients
INDIA'S growing expertise in robotic-assisted surgeries is becoming a major driver for international medical tourism.
2 min |
July 17, 2025
Chronicle Pharmabiz
India's 500+ pharma GCCs signal shift in global drug discovery landscape
INDIA is using its technology edge with artificial intelligence (AI) and machine learning (ML) to bolster its pharma global capability centres (GCCs) growth.
2 min |
July 17, 2025
Chronicle Pharmabiz
New standard input output norms announced for key pharma products
In a move aimed at boosting pharma exports and enhancing transparency in international trade, the Directorate General of Foreign Trade (DGFT) has announced the introduction of new Standard Input Output Norms (SIONs) for key pharma productsazithromycin dihydrate and ceftazidime powder.
1 min |
July 17, 2025
Chronicle Pharmabiz
'Indian pharma grapples with quality culture'
As global regulatory scrutiny intensifies, pharmaceutical companies are facing increasing pressure to not only meet compliance standards but to embed a robust quality culture into their very core operations.
2 min |
July 17, 2025
Chronicle Pharmabiz
Govt extends e-submission of CoPP till August 15
THE DCGI has extended the deadline for mandating online submission of WHO-GMP Certificate of Pharmaceutical Product (CoPP) till August 15, 2025 following concerns raised by various industry associations.
1 min |
July 17, 2025
Chronicle Pharmabiz
Next-gen hematology analyzers improve diagnostic accuracy
THE field of hematology, which focuses on the study of blood and its disorders, is foundational to clinical diagnostics.
4 min |
July 17, 2025
Chronicle Pharmabiz
Dr Lal PathLabs strengthens genomics capabilities
DR Lal PathLabs has expanded its genomics capabilities by adding Illumina's NovaSeq X Series to its dedicated genomics division, Genevolve.
1 min |
July 17, 2025
Chronicle Pharmabiz
Ayush, herbal products exports grew 0.5 per cent in May
EXPORT of Ayush and herbal products has reported a marginal growth of 0.5 per cent during the month of May, as compared to almost 1 per cent growth on a Year-over-year (YoY) basis, reported in the same month a year ago.
2 min |
July 17, 2025
Chronicle Pharmabiz
Telangana DCA intensifies anti-counterfeit drug drive
As a followup to last week's seizure of 'Levipil 500' (levetiracetam 500 mg) tablets from two premises in Hyderabad and Karimnagar, the DCA in Telangana arrested Manish Kumar, partner-cum-competent person of Arvind Pharma Distributors in Hyderabad's SBI Staff Colony, on July 8, 2025, for dealing with spurious (counterfeit) drugs.
2 min |
July 17, 2025
Chronicle Pharmabiz
Sanofi bags GCC Workplace Awards 2025
SANOFI Global Services received two accolades that highlight its leadership in the global capability centre (GCC) landscape at the recently concluded Zyoin Group GCC Workplace Summit and Awards2025, held in Bengaluru.
1 min |
July 17, 2025
Chronicle Pharmabiz
Kairali Ayurvedic Group opens centre in Jaipur
KAIRALI Ayurvedic Group, one of India's most trusted names in authentic Ayurveda healthcare, inaugurated its first-ever authentic Kerala Ayurveda wellness treatment centre in Jaipur, Rajasthan.
1 min |
July 17, 2025
Chronicle Pharmabiz
AMMOI opposes IMA's call to stop initiative at JIPMER
THE Ayurveda Medicine Manufacturers' Organisation of India (AMMOI) has countered the Indian Medical Association's (IMA) request to the Union health ministry that the government should withdraw from its decision to start an integrated medical course at the Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER) in Pondicherry, blending traditional medicine with mainstream healthcare.
1 min |
July 17, 2025
Chronicle Pharmabiz
NABL urges accredited labs to adopt ILAC MRA Mark
IN a significant push towards enhancing international recognition and trade facilitation, the National Accreditation Board for Testing and Calibration Laboratories (NABL) is actively guiding its accredited Conformity Assessment Bodies (CABs) to apply for permission to use the NABL accredited CAB combined ILAC MRA Mark. This move is aimed at reducing technical barriers to trade by reinforcing the global acceptance of accredited testing, calibration, and related services.
2 min |